Physician profile
Nancy F Rector
NPI 1538195086
$4,289.60
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $937 · 2020: $850 · 2021: $880 · 2022: $999 · 2023: $624.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $426 · Education: $198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $426.18 |
| Education | $198.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,032.87 | 2019-2023 | Trelegy Ellipta, Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $681.19 | 2019-2023 | Stiolto Respimat, Spiriva Respimat, Ofev |
| Astrazeneca Pharmaceuticals LP | $637.03 | 2019-2023 | Breztri |
| Regeneron Healthcare Solutions, INC. | $258.43 | 2019-2023 | Dupixent |
| Mallinckrodt Hospital Products INC. | $213.58 | 2020-2023 | Acthar |
| Mylan Specialty L.P. | $198.57 | 2019-2023 | Yupelri |
| Actelion Pharmaceuticals US, INC. | $182.49 | 2019-2023 | Opsumit, Uptravi |
| Grifols USA, LLC | $179.81 | 2019-2023 | Prolastin-C Liquid |
| Genzyme Corporation | $162.97 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $122.42 | 2019-2020 | |
| Advanced Respiratory, INC | $109.21 | 2019-2021 | |
| Fisher & Paykel Healthcare INC | $88.22 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $80.23 | 2020-2023 | Glassia |
| Mallinckrodt Enterprises LLC | $53.87 | 2019 | |
| Merck Sharp & Dohme LLC | $38.74 | 2019-2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $38.69 | 2022 | |
| Hologic Sales and Service, LLC | $30.24 | 2019 | |
| Abbvie INC. | $22.23 | 2022 | |
| Janssen Pharmaceuticals, INC | $20.53 | 2019 | |
| Nabriva Therapeutics, Plc | $19.49 | 2020 | |
| Baxter Healthcare | $19.44 | 2023 | Hillrom - Life 2000 Ventilation System |
| Pfizer INC. | $18.38 | 2019 | |
| Shire North American Group INC | $16.11 | 2019 | |
| Csl Behring | $14.64 | 2020 | |
| Inogen, INC. | $13.30 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $13.02 | 2021 | |
| Circassia INC. | $12.21 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $11.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Rector listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.